(Q31149161)

29 June 2017

1 reference

title

Structural neuroimaging of the basal ganglia in schizophrenic patients: a review (English)

1 reference

29 June 2017

0 references

0 references

0 references

Gerrit N Brandt

1

1 reference

29 June 2017

Raphael M Bonelli

series ordinal

2

1 reference

29 June 2017

publication date

1 January 2008

1 reference

Wiener Medizinische Wochenschrift

29 June 2017

published in

1 reference

29 June 2017

volume

158

1 reference

29 June 2017

issue

3-4

1 reference

29 June 2017

page(s)

84-90

1 reference

https://scigraph.springernature.com/pub.10.1007/s10354-007-0478-7

29 June 2017

exact match

0 references

cites work

Information processing and attention dysfunctions in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0478-7

Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0478-7

Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0478-7

Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0478-7

Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0478-7

Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0478-7

Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0478-7

Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

21 January 2018

1 reference

12 December 2020

The brain dopaminergic system. Pharmacological, behavioural and electrophysiological studies

1 reference

12 December 2020

Magnetic resonance imaging of brain in people at high risk of developing schizophrenia.

1 reference

12 December 2020

Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study

1 reference

12 December 2020

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

1 reference

12 December 2020

Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia

1 reference

12 December 2020

Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach.

1 reference

12 December 2020

Electrical sensitization of the meso-limbic dopaminergic system in rats: a pathogenetic model for schizophrenia.

1 reference

12 December 2020

Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function

1 reference

12 December 2020

A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly

1 reference

12 December 2020

Volumetric MRI measurement of caudate nuclei in antipsychotic-naive patients suffering from a first episode of psychosis

1 reference

12 December 2020

Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects.

1 reference

12 December 2020

Schizophrenia is (not simply) a neurodevelopmental disorder

1 reference

12 December 2020

Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics

1 reference

12 December 2020

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

12 December 2020

Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network

1 reference

12 December 2020

Magnetic resonance imaging findings of amygdala-anterior hippocampus shrinkage in male patients with schizophrenia.

1 reference

12 December 2020

Globus pallidus volume is related to symptom severity in neuroleptic naive patients with schizophrenia.

1 reference

12 December 2020

Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia.

1 reference

12 December 2020

Structural analysis of the basal ganglia in schizophrenia

1 reference

12 December 2020

Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study.

1 reference

12 December 2020

The current status of the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone

1 reference

12 December 2020

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

1 reference

12 December 2020

Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study

1 reference

12 December 2020

High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients

1 reference

12 December 2020

Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent.

1 reference

12 December 2020

Decreased caudate volume in neuroleptic-naive psychotic patients.

1 reference

12 December 2020

Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states

1 reference

12 December 2020

Decreased volume and increased asymmetry of the anterior limb of the internal capsule in patients with schizophrenia.

1 reference

12 December 2020

16. Brain morphological changes in 1st episode cases of schizophrenia: Are they progressive?

1 reference

12 December 2020

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

12 December 2020

An automated registration algorithm for measuring MRI subcortical brain structures.

1 reference

12 December 2020

Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms.

1 reference

12 December 2020

Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up study.

1 reference

12 December 2020

Structural Brain Abnormalities in Patients With Schizophrenia and Their Healthy Siblings

1 reference

12 December 2020

Antipsychotic drugs, neurotransmitters, and schizophrenia

1 reference

12 December 2020

Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia

1 reference

12 December 2020

The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics.

1 reference

12 December 2020

Striatal enlargement in rats chronically treated with neuroleptic.

1 reference

12 December 2020

Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task

1 reference

12 December 2020

Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and repeated administration

1 reference

12 December 2020

Computerized volume measurement of brain structure.

1 reference

12 December 2020

Longitudinal study of brain morphology in first episode schizophrenia

1 reference

12 December 2020

MRI anatomy of schizophrenia.

1 reference

12 December 2020

Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia.

1 reference

12 December 2020

MRI abnormalities in tardive dyskinesia.

1 reference

12 December 2020

Association between striatal reduction and poor Wisconsin card sorting test performance in patients with schizophrenia.

1 reference

12 December 2020

Changes in caudate volume with neuroleptic treatment

1 reference

12 December 2020

Caudate and putamen volumes in good and poor outcome patients with schizophrenia

1 reference

12 December 2020

10.1007/S10354-007-0478-7

Identifiers

DOI

1 reference

Dimensions Publication ID

29 June 2017

1011611808

0 references

1 reference